Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06906653Not ApplicableEnrolling By Invitation

Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy

Role: collaborator

NCT03524534Not ApplicableCompleted

The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study

Role: collaborator

NCT05606081Not ApplicableWithdrawn

Predicting Risk for Post-polypectomy Colorectal Cancer

Role: collaborator

All 3 trials loaded